跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Trelegy Ellipta - SFDA Drug Approval Details
Approvals
/
SFDA
/
Trelegy Ellipta
Authorized
NCE
Trelegy Ellipta
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
b279e8b83c5a0488
Company
Unknown
Type
NCE
Approval Details
Approval Id
b279e8b83c5a0488
Drug Approval Sfda Name
Trelegy Ellipta
Trade Name
Trelegy Ellipta
Generic Name
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE
Register Number
1102256864
Register Year
2025
Drug Type
NCE
Route Of Administration
Inhalation use
Package Type
Inhaler
Package Size
1
Size
30
Size Unit
dose
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
24 Months
Distribution Site
Pharmacy
Description Code
8000000274-200-100000073840
Price
236.8
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
b279e8b83c5a0488
Type
NCE
Back to SFDA Approvals